Published in Arch Pediatr Adolesc Med on December 01, 1999
Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ (2006) 1.88
Potential Use of Salivary Markers for Longitudinal Monitoring of Inflammatory Immune Responses to Vaccination. Mediators Inflamm (2016) 0.75
Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell (2016) 0.75
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53
Calcium-channel blockade and incidence of cancer in aged populations. Lancet (1996) 8.04
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg (1985) 7.14
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med (2000) 5.06
Do calcium channel blockers increase the risk of cancer? Am J Hypertens (1996) 4.75
Randomized phase II clinical trials. Cancer Treat Rep (1985) 3.19
Disability as a public health outcome in the aging population. Annu Rev Public Health (1996) 3.02
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med (1990) 2.97
Serum albumin level and physical disability as predictors of mortality in older persons. JAMA (1994) 2.66
Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA (1991) 2.51
Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ (1994) 2.51
HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA (1995) 2.46
Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc (1996) 2.32
The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials (2001) 2.06
Progressive versus catastrophic disability: a longitudinal view of the disablement process. J Gerontol A Biol Sci Med Sci (1996) 1.95
Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85
Physical activity and risk of severe gastrointestinal hemorrhage in older persons. JAMA (1994) 1.79
Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. Pediatr Infect Dis J (2001) 1.60
Postlicensure safety surveillance for varicella vaccine. JAMA (2000) 1.44
Hair loss after routine immunizations. JAMA (1997) 1.43
Board certification among preventive medicine residency graduates: characteristics, advantages, and barriers. Am J Prev Med (1995) 1.39
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 1.23
A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol (1987) 1.19
A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics (1989) 1.16
An efficient design for phase III studies of combination chemotherapies. Cancer Treat Rep (1985) 1.13
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med (1983) 1.12
Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg Am (1978) 1.06
Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS). Clin Infect Dis (1998) 1.03
New designs for the selection of treatments to be tested in randomized clinical trials. Stat Med (1994) 1.02
Randomization designs in comparative clinical trials. N Engl J Med (1984) 0.97
Risk factors for fatal heart attack in young women. Am J Epidemiol (1981) 0.95
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics (2000) 0.95
Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol (1996) 0.94
Surrogate endpoints. Br J Cancer (1993) 0.93
Proactive safety surveillance. Pharmacoepidemiol Drug Saf (2001) 0.91
Hospital and nursing home use in the last three months of life. J Aging Health (1996) 0.90
Medical care behind bars: Maryland prison system. Md Med J (1989) 0.90
Serum iron level, coronary artery disease, and all-cause mortality in older men and women. Am J Cardiol (1997) 0.90
Effect of age and severity of disability on short-term variation in walking speed: the Women's Health and Aging Study. J Clin Epidemiol (1996) 0.89
On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection. J Acquir Immune Defic Syndr (1990) 0.88
Antidepressant use in the elderly: association with demographic characteristics, health-related factors, and health care utilization. J Clin Epidemiol (1995) 0.87
Optimal two-stage designs for clinical trials with binary response. Stat Med (1988) 0.86
Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older persons. J Am Geriatr Soc (1996) 0.85
Automated external defibrillators. N Engl J Med (2001) 0.85
The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997. Pharmacoepidemiol Drug Saf (2001) 0.83
Syncope after immunization. Arch Pediatr Adolesc Med (1997) 0.83
Vertebral abnormalities associated with synthetic retinoid use. J Am Acad Dermatol (1984) 0.83
Surrogate end points in clinical trials. BMJ (1991) 0.83
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials. Control Clin Trials (1995) 0.82
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). J Clin Epidemiol (1998) 0.82
Disability and severe gastrointestinal hemorrhage. A prospective study of community-dwelling older persons. J Am Geriatr Soc (1994) 0.81
Results of second-look laparotomy in patients with early-stage ovarian carcinoma. Obstet Gynecol (1987) 0.81
Fatal myocardial infarction and the role of oral contraceptives. Am J Epidemiol (1980) 0.80
Gonorrhea prevalence in the Maryland state prisons. Sex Transm Dis (1990) 0.79
Factors associated with paranoid symptoms in a community sample of older adults. Gerontologist (1996) 0.79
Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994. J Pediatr (1997) 0.78
Characteristics of an endogenous glucocorticoid receptor stabilizing factor. J Biol Chem (1982) 0.78
Referral bias in tertiary care: the utility of clinical epidemiology. Mayo Clin Proc (1994) 0.77
Surrogate endpoints: the debate goes on. Pharmacoepidemiol Drug Saf (2002) 0.77
Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect. N Engl J Med (1986) 0.76
Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics (1998) 0.76
Statistical approaches and policies for the operations of Data and Safety Monitoring Committees. Am Heart J (2001) 0.76
Depressive symptoms in the elderly: association with total white blood cell count. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.76
Occult caffeine as a source of sleep problems in an older population. J Am Geriatr Soc (1995) 0.76
Series of jail suicides in Dade County, Florida. Med Sci Law (1990) 0.75
Blood pressure and serum creatinine. JAMA (1993) 0.75
A trial of RSV immune globulin in infants and young children: the FDA's view. N Engl J Med (1994) 0.75
HIV vaccines. Lancet (1997) 0.75
Randomized consent designs for clinical trials: an update. Stat Med (1992) 0.75
Commitment to quality care. Am J Public Health (1990) 0.75
Community-based HIV trials are rigorous, says NIH. Ann Intern Med (1993) 0.75
Issues in the design of drug trials for AIDS. Control Clin Trials (1990) 0.75
Resident opportunities at the newest US PHS agency. JAMA (1990) 0.75
Quality assurance and the treatment of hypertension. Md Med J (1989) 0.75
Correlates of severe or life-threatening toxic effects from trimetrexate. J Natl Cancer Inst (1988) 0.75
Prognostic factors for colon cancer. J Clin Oncol (1988) 0.75
Adequacy of training in preventive medicine and public health: a national survey of residency graduates. Acad Med (1996) 0.75
Shortage of preventive medicine physicians. N Y State J Med (1988) 0.75
Studies to compare treatment regimens: the randomized clinical trial and alternative strategies. JAMA (1981) 0.75